More
    Guided Solutions - Connecting Talent With Innovation/div>

    Clinical Trials

    CardioFocus has positive pulsed field ablation data for its Centauri system

    CardioFocus published 12-month data from a study of its pulsed field ablation (PFA) system. ECLIPSE AF, evaluated the safety and performance of the CardioFocus Centauri...

    NanoVibronix “achieves goals” of US trial pilot phase with UroShield

    NanoVibronix has completed the first phase of a randomised control trial with UroShield, the company’s disposable ultrasound device designed to prevent catheter-associated urinary tract...

    CathWorks completes enrolment in CAD treatment system trial

    CathWorks completed the enrolment for a randomised controlled trial (RCT), evaluating the FFRangio system in diagnosing and treating coronary artery disease (CAD). The Advancing Cath...

    Navigantis achieves 1st cases with VASCO Neurovascular surgical robot

    Navigantis achieved the first successful neurovascular clinical cases performed using its VASCO interventional robotic platform for patients with neurovascular disorders. The VASCO interventional robotic platform...

    SamanTree Medical’s Histolog scanner shows promise in breast surgery outcomes

    SamanTree Medical has revealed that its Histolog scanner, a confocal laser microscope, significantly decreased breast-conserving surgery (BCS) reoperation rates by 67% as observed in...

    Protaryx Medical completes first-in-human trial of transseptal puncture device

    US-based Protaryx Medical has completed a first-in-human trial of its transseptal puncture (TSP) device. The company’s trial enrolled five patients, with the TSP procedure carried...

    EndoQuest wins FDA IDE to study surgical robot in colorectal surgery

    EndoQuest Robotics announced it received FDA investigational device exemption (IDE) for a study of its surgical robot. The IDE allows the Houston, Texas-based company...

    ShiraTronics initiates FDA IDE study for implantable neuromod

    ShiraTronics announced it initiated its FDA investigational device exemption (IDE) pivotal trial for its neuromodulation therapy. The RELIEV-CM2 clinical study evaluates the company’s neuromodulation...

    Nervonik completes first human study of nerve stim tech for chronic pain

    Nervonik announced it completed the first-in-human clinical study of its peripheral nerve stimulation (PNS) device. The Los Angeles-based startup designed its proprietary device to enhance...
    123...48Page 1 of 48

    Latest articles

    Popular articles

    Featured

    Newsletter

    [hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

    © Copyright - Guided Solutions - Global Executive Search in Medical Devices